Skip to main content

Six to 12 Weeks of Cytisinicline Efficacious for Smoking Cessation

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 18, 2023 -- For smokers who want to quit, six or 12 weeks of cytisinicline is efficacious for smoking cessation, according to a study published in the July 11 issue of the Journal of the American Medical Association.

Nancy A. Rigotti, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the efficacy and tolerability of cytisinicline for smoking cessation when administered for six or 12 weeks versus placebo in a three-group, double-blind randomized trial. A total of 810 adults who smoked cigarettes daily and wanted to quit were randomly assigned to 3 mg of cytisinicline treatment three times daily for six or 12 weeks versus placebo (269, 270, and 271 participants, respectively), with follow-up to 24 weeks. All of the participants received behavioral support.

The researchers found that continuous abstinence rates were 25.3 versus 4.4 percent during weeks 3 to 6 and 8.9 versus 2.6 percent during weeks 3 to 24 for the six-week course of cytisinicline versus placebo (odds ratios, 8.0 and 3.7, respectively). For the 12-week course of cytisinicline versus placebo, continuous abstinence rates were 32.6 versus 7.0 percent and 21.1 versus 4.8 percent for weeks 9 to 12 and 9 to 24, respectively (odds ratios, 6.3 and 5.3, respectively). In less than 10 percent of each group, nausea, abnormal dreams, and insomnia occurred. Overall, 2.9 percent discontinued cytisinicline due to an adverse event; there were no drug-related serious adverse events reported.

"Cytisinicline reduced nicotine craving and was well tolerated by participants, who adhered to the treatment schedule at a high rate, even though the trial was conducted during the early phases of the U.S. COVID-19 pandemic," the authors write.

Several authors disclosed ties to biopharmaceutical companies, including Achieve Life Sciences, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis

TUESDAY, May 28, 2024 -- Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online...

E-Cigarette Use After Smoking May Up Risk for Lung Cancer

WEDNESDAY, May 22, 2024 -- Former cigarette smokers who use electronic cigarettes may have a higher risk for lung cancer than those who do not vape, according to a study presented...

Use of Electronic Cigarettes Tied to Earlier Age at Onset of Adult Asthma

FRIDAY, May 17, 2024 -- Past 30-day electronic nicotine delivery systems (ENDS) use among adults is associated with earlier ages of asthma onset, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.